Selective inhibition of hepatitis B virus internalization by oxysterol derivatives
Biochemical and Biophysical Research Communications · 2023-10 · 675 · 139-145
DOI: 10.1016/j.bbrc.2023.07.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023-10. Verfasst von Mizuki Oshima und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Virology II, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan; Department of Applied Biological Sciences, Tokyo Univer…. Hauptthemen laut MEDLINE: Hepatitis B, Symporters. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Japan Foundation for Applied Enzymology, AMED.
Abstract (Originalsprache)
Given that the current approved anti-hepatitis B virus (HBV) drugs suppress virus replication and improve hepatitis but cannot eliminate HBV from infected patients, new anti-HBV agents with different mode of action are urgently needed. In this study, we identified a semi-synthetic oxysterol, Oxy185, that can prevent HBV infection in a HepG2-based cell line and primary human hepatocytes. Mechanistically, Oxy185 inhibited the internalization of HBV into cells without affecting virus attachment or replication. We also found that Oxy185 interacted with an HBV entry receptor, sodium taurocholate cotransporting polypeptide (NTCP), and inhibited the oligomerization of NTCP to reduce the efficiency of HBV internalization. Consistent with this mechanism, Oxy185 also inhibited the hepatitis D virus infection, which relies on NTCP-dependent internalization, but not hepatitis A virus infection, and displayed pan-genotypic anti-HBV activity. Following oral administration in mice, Oxy185 showed sustained accumulation in the livers of the mice, along with a favorable liver-to-plasma ratio. Thus, Oxy185 is expected to serve as a useful tool compound in proof-of-principle studies for HBV entry inhibitors with this novel mode of action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Virology II, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan; Department of Applied Biological Sciences, Tokyo University of Science, Noda, 278-8510, Japan.
- MAX BioPharma, Inc., Santa Monica, CA, 90404, USA.
- Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
- Department of Virology II, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan.
- Department of Virology II, National Institute of Infectious Diseases, Tokyo, 162-8640, Japan; Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, 162-8655, Japan.
- CellFree Sciences. Co. Ltd., 3 Bunkyo-cho, Matsuyama, Ehime, 790-8577, Japan.
Förderung
- Japan Society for the Promotion of Science
- Japan Foundation for Applied Enzymology
- AMED
- Takeda Science Foundation
- Japan Science and Technology Agency
Zitieren
APA
Oshima, M., Stappenbeck, F., Ohashi, H., Iwamoto, M., Fukano, K., Kusunoki, A., Zheng, X., Wang, F., Morishita, R., Aizaki, H., Suzuki, R., Muramatsu, M., Kuramochi, K., Sureau, C., Parhami, F., & Watashi, K. (2023). Selective inhibition of hepatitis B virus internalization by oxysterol derivatives. Biochemical and Biophysical Research Communications, 675, 139-145. https://doi.org/10.1016/j.bbrc.2023.07.014
Vancouver
Oshima M, Stappenbeck F, Ohashi H, Iwamoto M, Fukano K, Kusunoki A, et al. Selective inhibition of hepatitis B virus internalization by oxysterol derivatives. Biochemical and Biophysical Research Communications. 2023;675:139-145. doi:10.1016/j.bbrc.2023.07.014
BibTeX
@article{Oshima2023,
author = {Oshima, Mizuki and Stappenbeck, Frank and Ohashi, Hirofumi and Iwamoto, Masashi and Fukano, Kento and Kusunoki, Atsuto and Zheng, Xin and Wang, Feng and Morishita, Ryo and Aizaki, Hideki and Suzuki, Ryosuke and Muramatsu, Masamichi and Kuramochi, Kouji and Sureau, Camille and Parhami, Farhad and Watashi, Koichi},
title = {Selective inhibition of hepatitis B virus internalization by oxysterol derivatives},
journal = {Biochemical and Biophysical Research Communications},
year = {2023},
volume = {675},
pages = {139--145},
doi = {10.1016/j.bbrc.2023.07.014}
}
EUVIMED